Cell-associated HIV RNA: a dynamic biomarker of viral persistence

被引：105

作者：

Pasternak, Alexander O. ^{[1
]}

Lukashov, Vladimir V. ^{[1
]}

Berkhout, Ben ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands

来源：

RETROVIROLOGY | 2013年 / 10卷

关键词：

Cell-associated HIV RNA; Virological biomarker; HIV-1; persistence; reservoir; Antiretroviral therapy; HIV cure; IMMUNODEFICIENCY-VIRUS TYPE-1; REAL-TIME PCR; ACTIVE ANTIRETROVIRAL THERAPY; BLOOD MONONUCLEAR-CELLS; LOW-LEVEL VIREMIA; CD4(+) T-CELLS; COURSE RALTEGRAVIR INTENSIFICATION; HIGHLY SENSITIVE METHODS; IN-SITU HYBRIDIZATION; MESSENGER-RNA;

D O I：

10.1186/1742-4690-10-41

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

In most HIV-infected individuals adherent to modern antiretroviral therapy (ART), plasma viremia stays undetectable by clinical assays and therefore, additional virological markers for monitoring and predicting therapy responses and for measuring the degree of HIV persistence in patients on ART should be identified. For the above purposes, quantitation of cell-associated HIV biomarkers could provide a useful alternative to measurements of viral RNA in plasma. This review concentrates on cell-associated (CA) HIV RNA with the emphasis on its use as a virological biomarker. We discuss the significance of CA HIV RNA as a prognostic marker of disease progression in untreated patients and as an indicator of residual virus replication and the size of the dynamic viral reservoir in ART-treated patients. Potential value

引用

收藏

页数：15

相关论文

共 167 条

[1] Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy [J].

Archin, N. M. ;

Liberty, A. L. ;

Kashuba, A. D. ;

Choudhary, S. K. ;

Kuruc, J. D. ;

Crooks, A. M. ;

Parker, D. C. ;

Anderson, E. M. ;

Kearney, M. F. ;

Strain, M. C. ;

Richman, D. D. ;

Hudgens, M. G. ;

Bosch, R. J. ;

Coffin, J. M. ;

Eron, J. J. ;

Hazuda, D. J. ;

Margolis, D. M. .

NATURE, 2012, 487 (7408) :482-U1650

[2] ALTERATIONS IN SPLICED AND UNSPLICED HIV-1-SPECIFIC RNA DETECTION IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF INDIVIDUALS WITH VARYING CD4-POSITIVE LYMPHOCYTE COUNTS [J].

ARENS, M ;

JOSEPH, T ;

NAG, S ;

MILLER, JP ;

POWDERLY, WG ;

RATNER, L .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (12) :1257-1263

[3] LTR Real-Time PCR for HIV-1 DNA Quantitation in Blood Cells for Early Diagnosis in Infants Born to Seropositive Mothers Treated in HAART Area (ANRS CO 01) [J].

Avettand-Fenol, Veronique ;

Chaix, Marie-Laure ;

Blanche, Stephane ;

Burgard, Marianne ;

Floch, Corinne ;

Toure, Kadidia ;

Allemon, Marie-Christine ;

Warszawski, Josiane ;

Rouzioux, Christine .

JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (02) :217-223

[4] MOLECULAR PROFILE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN SYMPTOMLESS PATIENTS AND IN PATIENTS WITH AIDS [J].

BAGNARELLI, P ;

MENZO, S ;

VALENZA, A ;

MANZIN, A ;

GIACCA, M ;

ANCARANI, F ;

SCALISE, G ;

VARALDO, PE ;

CLEMENTI, M .

JOURNAL OF VIROLOGY, 1992, 66 (12) :7328-7335

[5] Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo [J].

Bagnarelli, P ;

Valenza, A ;

Menzo, S ;

Sampaolesi, R ;

Varaldo, PE ;

Butini, L ;

Montroni, M ;

Perno, CF ;

Aquaro, S ;

Mathez, D ;

Leibowitch, J ;

Balotta, C ;

Clementi, M .

JOURNAL OF VIROLOGY, 1996, 70 (11) :7603-7613

[6] Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells [J].

Bailey, JR ;

Sedaghat, AR ;

Kieffer, T ;

Brennan, T ;

Lee, PK ;

Wind-Rotolo, M ;

Haggerty, CM ;

Kamireddi, AR ;

Liu, Y ;

Lee, J ;

Persaud, D ;

Gallant, JE ;

Cofrancesco, J ;

Quinn, TC ;

Wilke, CO ;

Ray, SC ;

Siliciano, JD ;

Nettles, RE ;

Siliciano, RF .

JOURNAL OF VIROLOGY, 2006, 80 (13) :6441-6457

[7] Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy [J].

Bailey, Justin R. ;

Lassen, Kara G. ;

Yang, Hung-Chih ;

Quinn, Thomas C. ;

Ray, Stuart C. ;

Blankson, Joel N. ;

Siliciano, Robert F. .

JOURNAL OF VIROLOGY, 2006, 80 (10) :4758-4770

[8] Short-Course Raltegravir Intensification Does Not Increase 2 Long Terminal Repeat Episomal HIV-1 DNA in Patients on Effective Antiretroviral Therapy [J].

Besson, Guillaume J. ;

McMahon, Deborah ;

Maldarelli, Frank ;

Mellors, John W. .

CLINICAL INFECTIOUS DISEASES, 2012, 54 (03) :451-453

[9] Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors [J].

Blankson, Joel N. ;

Bailey, Justin R. ;

Thayil, Seema ;

Yang, Hung-Chih ;

Lassen, Kara ;

Lai, Jun ;

Gandhi, Shiv K. ;

Siliciano, Janet D. ;

Williams, Thomas M. ;

Siliciano, Robert F. .

JOURNAL OF VIROLOGY, 2007, 81 (05) :2508-2518

[10] Demonstration of de novo HIV type 1 production by detection of multiply spliced and unspliced HIV type 1 RNA in paraffin-embedded tonsils [J].

Brachtel, EF ;

Mascola, JR ;

Wear, DJ ;

Ehrenberg, PK ;

Dayhoff, DE ;

Sanders-Buell, E ;

Michael, NL ;

Frankel, SS .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (11) :785-790

← 1 2 3 4 5 6 7 8 9 10 →